| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 31 |
| 1 | ASPIRIN | 30 |
| 2 | ASPIRIN 325 MG | 30 |
| 3 | ASPIRIN 81 MG | 30 |
| 4 | SIMVASTATIN | 29 |
| 5 | ALBUTEROL SULFATE | 27 |
| 6 | IBUPROFEN | 27 |
| 7 | METHOTREXATE | 25 |
| 8 | PREDNISONE | 25 |
| 9 | IBUPFROFEN | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LULICONAZOLE | 1 | 0.0057 |
| 1 | EUCALYPTOL, MENTHOL, UNSPECIFIED FORM, METHYL SALICYLATE, AND THYMOL | 1 | 0.0045 |
| 2 | EMAPALUMAB-LZSG | 1 | 0.0042 |
| 3 | EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL | 1 | 0.0042 |
| 4 | CLEVIDIPINE | 1 | 0.0027 |
| 5 | BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE | 1 | 0.0025 |
| 6 | NIVOLUMAB AND RELATLIMAB-RMBW | 1 | 0.0019 |
| 7 | PENICILLIN G SODIUM | 2 | 0.0017 |
| 8 | HYDROCORTISONE SODIUM SUCCINATE | 6 | 0.0015 |
| 9 | RESLIZUMAB | 1 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 86 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 84 |
| 2 | HMG-CoA Reductase Inhibitor [EPC] | 31 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 30 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 29 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 27 |
| 6 | Platinum-based Drug [EPC] | 25 |
| 7 | Proton Pump Inhibitor [EPC] | 22 |
| 8 | Benzodiazepine [EPC] | 21 |
| 9 | Vitamin B12 [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon gamma Blocker [EPC] | 1 | 0.0042 |
| 1 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 2 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Interferon gamma [EPC] | 1 | 0.0007 |
| 4 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 4 | 0.0005 |
| 5 | Thyroid Hormone Synthesis Inhibitor [EPC] | 5 | 0.0005 |
| 6 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 7 | Phosphodiesterase 3 Inhibitor [EPC] | 3 | 0.0005 |
| 8 | beta Lactamase Inhibitor [EPC] | 2 | 0.0004 |
| 9 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |